Search

everythinglearnresearchcommunity

for

Search:↓

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Testosterone increases muscle mass regardless of DHT conversion blocking.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Adrenarche increases adrenal androgens around age 6, affecting hair growth and development.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Common baldness treatments include cosmetic methods, medication like minoxidil, and surgery, but no cure exists.

PM-9, like finasteride, may help treat certain diseases by blocking a key enzyme.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Hormones, especially DHT, affect hair loss and growth, and targeting specific enzymes may help treat hair loss.

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Androgenetic alopecia is common hair loss due to genetics and DHT.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Hair loss gene linked to prostate issues.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.